Rilan相关文献与解析，生知库 | 链接生命科学的每一步

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors

Kirsten 大鼠肉瘤病毒癌基因同源物 (KRAS) 突变肿瘤的免疫状态和联合免疫疗法进展

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.21147/j.issn.1000-9604.2024.04.06

He, Dongsheng; Bai, Rilan; Chen, Naifei; Cui, Jiuwei

Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials

晚期非小细胞肺癌患者在接受铂类化疗诱导治疗后，采用安罗替尼进行维持治疗：两项单臂试验的汇总分析

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000038459

Liu, Yiqian; Miao, Liyun; Chen, Xiao; Zhu, Xiaoli; Li, Yan; He, Jingdong; Chen, Ping; Dai, Shengbin; Liu, Ziling; Ma, Kewei; Wang, Nanya; Zhao, Yuguang; Chen, Naifei; Song, Wei; Bai, Rilan; Cui, Jiuwei; Shu, Yongqian

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

表皮生长因子受体复合物及其伴随突变：精准治疗策略的进展

期刊:Chinese Medical Journal

影响因子:7.3

doi:10.1097/CM9.0000000000002548

Li, Wenqian; Bai, Rilan; Guo, Hanfei; Cui, Jiuwei

信号转导

发表日期：2023

文献求助收藏

Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies

EGFR突变阳性非小细胞肺癌的精准靶向治疗：困境与应对策略

期刊:Thoracic Cancer

影响因子:2.3

doi:10.1111/1759-7714.14858

Meng, Ying; Bai, Rilan; Cui, Jiuwei

Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives

免疫疗法在神经内分泌肿瘤中的潜在新应用：免疫图谱、现状及未来展望

期刊:Cancer Biology & Medicine

影响因子:8.4

doi:10.20892/j.issn.2095-3941.2022.0489

Bai, Rilan; Li, Wenqian; Cui, Jiuwei

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

针对肿瘤微环境的免疫治疗策略的研发正在如火如荼地进行中。

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2022.890166

Bai, Rilan; Cui, Jiuwei

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

晚期非小细胞肺癌中罕见EGFR 20号外显子插入突变的治疗探索：突破重重阻碍

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-021-03840-y

Bai, Rilan; Chen, Xiao; Song, Wei; Tian, Huimin; Cui, Jiuwei

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC

靶向治疗联合免疫疗法治疗伴有腋窝淋巴结转移的乳腺浸润性导管癌和化生性鳞状细胞癌患者

期刊:Thoracic Cancer

影响因子:2.3

doi:10.1111/1759-7714.14602

Bai, Rilan; Jia, Lin; Gao, Yangyang; Sun, Xu; Chen, Naifei; Lv, Zheng; Cui, Jiuwei

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

免疫检查点抑制剂相关不良事件的特征和预测因素分析

期刊:Cancer Biology & Medicine

影响因子:8.4

doi:10.20892/j.issn.2095-3941.2021.0052

Bai, Rilan; Chen, Naifei; Chen, Xiao; Li, Lingyu; Song, Wei; Li, Wei; Zhao, Yuguang; Zhang, Yongfei; Han, Fujun; Lyu, Zheng; Cui, Jiuwei

免疫/内分泌

发表日期：2021

文献求助收藏

Regulation of fatty acid synthase on tumor and progress in the development of related therapies

肿瘤中脂肪酸合成酶的调控及其相关疗法的发展进展

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors

Kirsten 大鼠肉瘤病毒癌基因同源物 (KRAS) 突变肿瘤的免疫状态和联合免疫疗法进展

Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials

晚期非小细胞肺癌患者在接受铂类化疗诱导治疗后，采用安罗替尼进行维持治疗：两项单臂试验的汇总分析

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

表皮生长因子受体复合物及其伴随突变：精准治疗策略的进展

Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies

EGFR突变阳性非小细胞肺癌的精准靶向治疗：困境与应对策略

Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives

免疫疗法在神经内分泌肿瘤中的潜在新应用：免疫图谱、现状及未来展望

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

针对肿瘤微环境的免疫治疗策略的研发正在如火如荼地进行中。

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

晚期非小细胞肺癌中罕见EGFR 20号外显子插入突变的治疗探索：突破重重阻碍

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC

靶向治疗联合免疫疗法治疗伴有腋窝淋巴结转移的乳腺浸润性导管癌和化生性鳞状细胞癌患者

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

免疫检查点抑制剂相关不良事件的特征和预测因素分析